Stocks · Healthcare · Medical - Healthcare Plans
Progyny, Inc. PGNY
$25.23 +1.53% Close, Oct 2, 2026 · NASDAQ · Market cap $1.98B
High qualityInexpensive vs sectorLow risk
Next earnings report: Nov 5, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Diluted EPS over the last four quarters was $0.92, up 55.9% year over year.
- The shares trade at 27.4× trailing earnings, lower than 95% of the company's own readings over the past five years.
- The diluted share count fell 8.4% in a year, mainly through buybacks.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Bottom 42%
- EPS growth (TTM, YoY)Top 25%
- FCF growth (TTM, YoY)Top 46%
- Revenue growth, 3-year CAGRTop 34%
- Revenue growth accelerationBottom 41%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 8%
- Gross marginBottom 16%
- Operating marginTop 29%
- Cash conversion (OCF / net income)Top 10%
- Accruals (lower is better)Top 10%
- Net debt / EBITDA (lower is better)Top 19%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldTop 15%
- Free-cash-flow yieldTop 6%
- EBITDA / enterprise valueTop 17%
- Sales / enterprise valueTop 16%
- P/E vs own 5-year history (lower is better)Top 15%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthTop 48%
- 6-month returnTop 18%
- 1-year return vs S&P 500Top 45%
- Distance from 52-week highTop 38%
- Trend checklist (0–4)Top 39%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersBottom 31%
- Consecutive EPS beatsTop 25%
- Share of analysts rating BuyBottom 39%
- Upside to consensus price targetBottom 40%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Top 14%
- Maximum drawdown, 3 yearsTop 45%
- Beta vs S&P 500 (lower is better)Top 22%
- Net debt / EBITDA (lower is better)Top 19%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 6.6% | 5.5% | ↓ |
| EPS growth (YoY) | 35.1% | 55.9% | ↑ |
| Gross margin | 22.3% | 24.6% | ↑ |
| Operating margin | 6.2% | 8.6% | ↑ |
| FCF margin | 15.3% | 16.6% | ↑ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 5.5% | 6.6% | ↓ | Bottom 42% |
| EPS growth (TTM, YoY) | 55.9% | 35.1% | ↑ | Top 25% |
| Gross margin | 24.6% | 22.3% | ↑ | Bottom 16% |
| Operating margin | 8.6% | 6.2% | ↑ | Top 29% |
| Net margin | 6.0% | 4.3% | ↑ | — |
| Free-cash-flow margin | 16.6% | 15.3% | ↑ | — |
| Return on invested capital | 15.3% | — | Top 8% | |
| Revenue growth, 3-year CAGR | 17.9% | — | Top 34% |
Quality of earnings and balance sheet
- Cash conversion (OCF / net income)Above 1× means profits are backed by cash.
- 3.00×
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -23.5%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 9.7%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- -10.8 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- -0.99×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- 17.60%
- Shareholder yield
- 17.60%
- Share count change, 1 year
- -8.4%
- Share count change, 3-year CAGR
- -6.5%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 7, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 3
- Beats in the last 8 reports
- 5 of 8
- Average EPS surprise, last 4
- -8.1%
- Average 2-day reaction, last 8
- -0.4%
- Positive 20 days after report
- 3 of 8
Analysts
- Consensus price target
- $35.50
- Target vs current price
- +40.7%
- Analysts with a rating
- 20
- Share rating Buy or Strong Buy
- 70%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 6, 2026 | +7.5% | -3.7% | -19.0% | -16.2% | — |
| May 7, 2026 | +17.2% | +2.5% | +25.7% | +36.3% | +68.6% |
| Feb 26, 2026 | +2.0% | +4.3% | -16.6% | -16.8% | +15.8% |
| Nov 6, 2025 | -59.0% | -4.6% | +27.5% | +27.9% | +23.1% |
| Aug 7, 2025 | +17.6% | -1.8% | -1.8% | +0.3% | -20.6% |
| May 8, 2025 | -5.5% | -0.2% | -6.7% | -8.8% | -1.0% |
| Feb 27, 2025 | +9.1% | -0.5% | -5.7% | -5.0% | -9.2% |
| Nov 12, 2024 | -23.1% | +0.7% | -18.5% | -7.7% | +31.0% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 6, 2026 | $0.36 | $0.33 | +7.5% | $350.5M |
| May 7, 2026 | $0.30 | $0.26 | +17.2% | $328.5M |
| Feb 26, 2026 | $0.15 | $0.15 | +2.0% | $318.4M |
| Nov 6, 2025 | $0.16 | $0.39 | -59.0% | $313.3M |
| Aug 7, 2025 | $0.20 | $0.17 | +17.6% | $332.9M |
| May 8, 2025 | $0.18 | $0.19 | -5.5% | $324.0M |
| Feb 27, 2025 | $0.12 | $0.11 | +9.1% | $298.4M |
| Nov 12, 2024 | $0.11 | $0.14 | -23.1% | $286.6M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| P/E (trailing) | 27.4× | 56.3× | 5th | Top 15% |
| P/E (forward) | 19.6× | — | — | — |
| EV / EBITDA | 14.6× | — | — | Top 17% |
| EV / Sales | 1.41× | — | — | Top 16% |
| Free-cash-flow yield | 11.03% | — | — | Top 6% |
| Earnings yield | 3.65% | — | — | Top 15% |
P/E over the past five years
Range 27.2× – 126.7× since Jun 30, 2021. Each point: price on the filing date divided by trailing-twelve-month EPS known then.
What moved the stock over the past year
- Price return, 1 year
- +18.9%
- Earnings per share growth (TTM)
- +55.9%
- Change in P/E multiple
- -21.1%
Most of the move came from earnings growth.
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✗ Price above 50-day average
- ✓ Price above 200-day average
- ✓ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 102
- 50-day average slope (20 days)
- -6.0%
- 200-day average slope (20 days)
- +0.3%
- Distance from 50-day average
- -7.4%
- Distance from 200-day average
- +4.2%
- RSI (14)
- 39.8
- Relative volume
- 0.78×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 34.0%
- Volatility vs own 5-year history
- 8th percentile · Low for this stock
- Beta vs S&P 500 (2 years, weekly)
- 0.63
- Correlation with S&P 500
- 0.20
- Current drawdown from 1-year high
- -22.0%
- Maximum drawdown, 3 years
- -67.2%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Nov 8, 2021 | Nov 19, 2024 | -79.5% | 762 days | Not yet recovered |
| Jun 7, 2021 | Aug 17, 2021 | -33.1% | 50 days | 58 days (Nov 8, 2021) |
| Feb 24, 2021 | Mar 4, 2021 | -23.8% | 6 days | 36 days (Apr 26, 2021) |
| Apr 28, 2021 | May 12, 2021 | -18.3% | 10 days | 8 days (May 24, 2021) |
| Oct 5, 2020 | Oct 30, 2020 | -18.2% | 19 days | 10 days (Nov 13, 2020) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $1.98B
- P/E (TTM)
- 27.4
- EPS, diluted (TTM)
- $0.92
- Revenue (TTM)
- $1.31B
- 52-week range
- $16.10 – $33.07
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $500.6M | $786.9M | $1.09B | $1.17B | $1.29B |
| Gross profit | $112.1M | $167.3M | $238.8M | $253.4M | $304.5M |
| Operating income | $32.3M | $23.3M | $62.2M | $67.5M | $85.3M |
| Net income | $65.8M | $30.4M | $62.0M | $54.3M | $58.5M |
| EPS (diluted) | $0.66 | $0.30 | $0.62 | $0.57 | $0.65 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $286.6M | $298.4M | $324.0M | $332.9M | $313.3M | $318.4M | $328.5M | $350.5M |
| Net income | $10.4M | $10.5M | $15.1M | $17.1M | $13.9M | $12.5M | $24.2M | $28.1M |
| EPS (diluted) | $0.11 | $0.12 | $0.17 | $0.19 | $0.15 | $0.14 | $0.29 | $0.34 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | $26.0M | $80.4M | $188.8M | $179.1M | $210.2M |
| Capital expenditure | -$2.1M | -$3.2M | -$3.6M | -$5.4M | -$18.4M |
| Free cash flow | $23.9M | $77.2M | $185.2M | $173.7M | $191.8M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | $4.3M | $4.2M | $6.1M | -$297.9M | -$80.4M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $236.9M
- Total assets
- $715.8M
- Total liabilities
- $262.6M
- Total debt
- $27.0M
- Net debt
- -$125.7M
- Shareholders’ equity
- $453.3M
As of Jun 30, 2026 (filed Aug 7, 2026).
Short interest
- Shares sold short
- 4,707,672
- Days to cover
- 4.61
- Change vs previous report
- +5.8%
FINRA short interest, settlement date Sep 15, 2026.